In This Article:
The market is up 1.6% over the last week, with the Information Technology sector up 4.2%. In the last year, the market has climbed 22%, and earnings are forecast to grow by 15% annually. In this thriving environment, identifying high-growth tech stocks that align with these optimistic trends can be crucial for investors looking to capitalize on future opportunities.
Top 10 High Growth Tech Companies In The United States
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
Super Micro Computer | 20.49% | 27.13% | ★★★★★★ |
Sarepta Therapeutics | 24.13% | 44.72% | ★★★★★★ |
TG Therapeutics | 28.39% | 43.54% | ★★★★★★ |
Invivyd | 42.91% | 70.39% | ★★★★★★ |
Ardelyx | 27.44% | 65.92% | ★★★★★★ |
G1 Therapeutics | 27.57% | 57.75% | ★★★★★★ |
Ascendis Pharma | 39.71% | 68.43% | ★★★★★★ |
Travere Therapeutics | 26.68% | 68.81% | ★★★★★★ |
Seagen | 22.57% | 71.80% | ★★★★★★ |
ImmunoGen | 26.00% | 45.85% | ★★★★★★ |
Click here to see the full list of 251 stocks from our US High Growth Tech and AI Stocks screener.
We're going to check out a few of the best picks from our screener tool.
AVITA Medical
Simply Wall St Growth Rating: ★★★★★☆
Overview: AVITA Medical, Inc., along with its subsidiaries, operates as a regenerative medicine company in the United States and internationally, with a market cap of $250.89 million.
Operations: The company generates revenue primarily through the sale of Recell Devices, amounting to $54.14 million. Operating in the regenerative medicine sector, it focuses on innovative medical solutions across various markets.
AVITA Medical's recent developments highlight its dynamic growth potential in the tech and healthcare sectors. The company reported a 29.79% increase in second-quarter revenue to $15.2 million, despite a net loss of $15.39 million, reflecting significant investment in R&D and market expansion efforts. With an expected annual revenue growth rate of 26.7%, AVITA is poised for substantial advancement, further bolstered by their exclusive partnership with Regenity Biosciences to develop innovative regenerative products.
-
Take a closer look at AVITA Medical's potential here in our health report.
-
Evaluate AVITA Medical's historical performance by accessing our past performance report.
Verra Mobility
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Verra Mobility Corporation offers smart mobility technology solutions and services across the United States, Australia, Canada, and Europe, with a market cap of $4.45 billion.
Operations: Verra Mobility generates revenue primarily from three segments: Parking Solutions ($84.39 million), Commercial Services ($392.57 million), and Government Solutions ($376.14 million). The company's offerings span multiple regions, including the United States, Australia, Canada, and Europe.